 | Up a level |
Flinn, Ian W, Miller, Carole B, Ardeshna, Kirit M, Tetreault, Scott, Assouline, Sarit E, Mayer, Jiri, Merli, Michele, Lunin, Scott D, Pettitt, Andrew R 
ORCID: 0000-0002-0907-8950, Nagy, Zoltan et al (show 13 more authors)
(2019)
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.
JOURNAL OF CLINICAL ONCOLOGY, 37 (11).
912-+.
Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023)
Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib.
Scientific reports, 13 (1).
p. 3793.
Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023)
Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib.
Scientific reports, 13 (1).
3793-.
Till, Kathleen J ORCID: 0000-0002-3172-5771, Abdullah, Mariah, Alnassfan, Tahera, Janet, Gallardo Zapata, Marks, Thomas, Coma, Silvia, Weaver, David T, Pachter, Jonathan A, Pettitt, Andrew R and Slupsky, Joseph R ORCID: 0000-0002-7410-9004
(2023)
Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib.
Scientific reports, 13 (1).
3793-.